Registro:

Referencias:

• Slaga, T.J., Mechanisms involved in two-stage carcinogenesis in mouse skin (1984) Mechanisms of Tumor Promotion, Tumour Promotion and Skin Carcinogenesis, 2, pp. 1-16. , Slaga TJ, editor. Boca Raton: CRC Press
• Tilly, B.C., Tertoolen, L.G., Remorie, R., Ladoux, A., Verlaan, I., De Laat, S.W., Histamine as a growth factor and chemoattraetant for human carcinoma and melanoma cells: Action through Ca2+ mobilizing H1 receptors (1990) J Cell Biol, 11, pp. 1211-1215
• Davio, C., Baldi, A., Mladovan, A., Cricco, G., Fitzsimons, C., Bergoc, R., Expression of histamine receptors in different cell lines derived from mammary gland and human breast carcinomas (1995) Inflamm Res, 44 (1 SUPPL.), pp. 70-71
• Fischer, S., Patrick, K.E., Patamalai, B., Slaga, T.J., Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes (1990) Carcinogenesis, 11, pp. 991-996
• Ash, A.S.F., Schild, H.V., Receptors mediating some actions of histamine (1986) Br J Pharmacol Chemother, 27, pp. 427-439
• Hill, S.J., Distribution, properties, and functional characteristics of three classes of histamine receptor (1990) Pharm Rev, 42, pp. 45-83
• Leurs, R., Smit, M.J., Timmerman, H., Molecular pharmacological aspects of histamine receptors (1995) Pharmacol Ther, 66, pp. 413-463
• Mitsuhashi, M., Payan, D.G., Functional diversity of histamine and histamine receptors (1992) J Invest Dermatol, 98, pp. 85-111
• Davio, C., Cricco, G., Bergoc, R., Rivera, E., H1 and H2 histamine receptors in experimental carcinomas with an atypical coupling to signal transducers (1995) Biochem Pharmacol, 50, pp. 91-96
• Cricco, G., Davio, C.A., Fitzsimons, C.P., Engel, N., Bergoc, R.M., Rivera, E.S., Hislamine as an autocrine growth factor in experimental carcinomas (1994) Agents Actions, 43, pp. 17-20
• Aldaz, C.M., Conti, C.J., Giménev, I.B., Slaga, T.J., Klein-Szanto, A.J.P., Cutaneous changes during prolonged application of 12-O-tetradecanoyl-phorbol-13-acetate on mouse skin and residual effects after cessation of treatment (1985) Cancer Res, 45, pp. 2753-2759
• Norrby, K., Intradermal mast-cell secretion causing cutaneous mitogenesis (1983) Virchows Arch Abt B Zellpath, 42, pp. 263-269
• Leschke, C., Elz, S., Garbarg, M., Schunack, W., Synthesis and H1 receptor agonist activity of a series of 2-phenylhistamine. 2-heteroarylhistamines and analogues (1995) J Med Chem, 38, pp. 1287-1294
• Parsons, M.E., Owen, D.A., Ganellin, C.R., Durant, G.J., Dimaprit(S3-(N,N-dimethylamino)propylisothiourea) - A highly specific histamine H2-receptor agonist. Part I, Pharmacology (1977) Agents Actions, 7, pp. 31-37
• Freter, C.E., Lippman, M.E., Cheville, A., Zinn, S., Gelmann, E.P., Alterations in phosphoinositide metabolism associated with 17β-estradiol and growth factor treatment of MCF-7 breast cancer cells (1988) Mol Endocrinol, 2, pp. 159-166
• Enerbäck, L., Mast cells in rat gastrointestinal mucosa II: Dye binding and metachromatic properties (1966) Acta Pathol Microbiol Scand, 66, pp. 303-312
• Kitamura, Y., Taguchi, T., Yokoyama, M., Tamai, M., Yamatodani, A., Watanabe, T., Increase in histidine decarboxylase activity in mouse skin after application of tumor promoters (1984) Cellular Interactions by Environmental Tumor Promoters, pp. 327-334. , Fuyiki et al. editors. Japan Sci Soc Press, Tokyo
• Watanabe, T., Taguchi, Y., Sasaki, K., Tsuyama, K., Kitamura, Y., Increases of histidine decarboxylase activity in mouse skin after application of the tumor promoter tetradecanoyl phorbol acetate (1981) Biochem Biophys Res Commun, 100, pp. 427-432
• Malaviya, K., Morrison, A.R., Pentlamol, A.P., Histamine in human epidermal cells is induced by ultraviolet light injury (1996) J Invest Dermatol, 1106, pp. 785-789
• Engel, N., Cricco, G., Davio, C., Martin, G., Croci, M., Fitzsimons, C., Histamine regulates the expression of histidine decabroxylase in N-nitroso-N-methylurca (NMU)-induced mammary tumors in rats (1996) Inflamm Res, 45 (1 SUPPL.), pp. S64-5
• Davio, C., Martin, G., Cricco, G., Fitzsimons, C., Bergoc, R., Rivera, E., Role of histamine on growth and differentiation of the rat mammary gland (1994) Agents Actions, 41, pp. 115-117
• Lemos, B., Davio, C., Gass, H., Gonzalez, P., Cricco, G., Martin, G., Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas (1995) Inflamm Res, 44 (1 SUPPL.), pp. 68-69
• Fiore-Donati, L., Debenedictis, G., Chieco-Bianchi, L., Development of mast cell reaction during chemical skin carcinogenesis of mouse (1962) Nature (Lond), 193, pp. 287-293
• Saiti, H., Sanai, Y., Nakamura, H., Watanabe, N., Ito, T., Nagai, Y., Enhancement of clonal proliferation of mouse mast cells by tumor-promoting phorbol ester (1984) Cancer Res, 44, pp. 2110-2114
• De Rey, B.M., Palmieri, M.A., Durán, H.A., Mast cell phenotypic changes in skin of mice during benzoyl peroxide-induced tumor promotion (1994) Tumor Biol, 15, pp. 166-174
• Mitsuhashi, M., Mitsuhashi, T., Payan, D.G., Multiple signalling pathways of histamine H2 receptors (1989) J Biol Chem, 264, pp. 18356-18362
• Klinker, S.F., Wenzelseifert, K., Seifert, R., G-protcin-coupled receptors in HL-60 human leukemia cells (1996) Gen Pharmacol, 27, pp. 33-54
• Nishizuka, Y., The role of protein kinase C in cell surface signal transduction and tumor promotion (1984) Nature, 308, pp. 693-698
• Marks, F., Gschwendt, M., Protein kinase C and skin tumor promotion (1995) Mutation Res, 333, pp. 161-172
• Stabel, S., Parker, P.J., Protein kinase C (1991) Pharmacol Ther, 51, pp. 71-95
• Fleischman, L.F., Chahwala, S.B., Cantley, L., Ras-transformed cells: Altered levels of phosphatidylinositol 4,5 biphosphates and catabolites (1986) Science, 231, pp. 407-410
• Vintermyr, O.K., Bøe, R., Brustugon, O.T., Maronde, E., Aakuaag, A., Døskeland, S.O., Cyclic adenosine monophosphate analogs 8-Cl-and 8-NH2cAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (1995) Endocrinology, 136, pp. 2513-2519
• Quintanilla, M., Brown, K., Ramsden, M., Baimain, A., Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis (1986) Nature, 322, pp. 78-80
• Zarbl, H., Sukumur, S., Arthur, A., Martin-Zanca, D., Barbacid, M., Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats (1985) Nature, 315, pp. 382-385
• Blackmore, P.F., Oakes, S.G., Somers, K.D., Altered H, histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes (1992) Oncogene, 7, pp. 2053-2057
• Kenakim, T., Agonist-receptor efficacy II: Agonist trafficking of receptors signals (1995) TIPS, 16, pp. 232-238
• Orange, P.R., Heath, P.R., Wright, S.R., Pearson, R.C.A., Allclic variation of the human histamine H2 receptor gene (1996) NeuroReport, 7, pp. 1293-1296
• Burde, R., Seifert, R., Stimulation of hislamine H2- (and H1)-receptors activates Ca2+ influx in all-trans-retinoic acid-differentiated HL-60 cells independently of phospholipase C or adenylyl cyclase (1996) Naunyn-Schmiedeberg's Arch Pharmacol, 353, pp. 123-129

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------